Global Information
회사소개 | 문의 | 비교리스트

세계의 프로스타글란딘 시장 규모 조사 : 종류별(인간 프로스타글란딘, 동물용 프로스타글란딘), 용도별(심혈관, 소화기, 산부인과, 안과, 기타), 지역별

Global Prostaglandin Market Size study, by Type (Human Prostaglandin, Veterinary Prostaglandin), Application (Cardiovascular, Digestive, Gynecological & Obstetrical, Ophthalmologic, Others) and Regional Forecasts 2019-2026

리서치사 Bizwit Research & Consulting LLP
발행일 2019년 05월 상품 코드 871552
페이지 정보 영문
가격
US $ 4,950 ₩ 5,952,000 Unprintable PDF (Single User License)
US $ 6,250 ₩ 7,515,000 Printable PDF (Enterprise License)


세계의 프로스타글란딘 시장 규모 조사 : 종류별(인간 프로스타글란딘, 동물용 프로스타글란딘), 용도별(심혈관, 소화기, 산부인과, 안과, 기타), 지역별 Global Prostaglandin Market Size study, by Type (Human Prostaglandin, Veterinary Prostaglandin), Application (Cardiovascular, Digestive, Gynecological & Obstetrical, Ophthalmologic, Others) and Regional Forecasts 2019-2026
발행일 : 2019년 05월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 프로스타글란딘(Prostaglandin) 시장에 대해 조사했으며, 종류·용도·지역별 시장 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 정리했습니다.

목차

제1장 주요 요약

  • 시장 현황
  • 주요 동향
  • 전체 및 부문별 시장 예측
    • 종류별
    • 용도별
    • 지역별
  • 조사 방법
  • 조사 가정

제2장 세계의 프로스타글란딘 시장 정의와 범위

  • 연구 목적
  • 시장 정의와 범위
    • 산업 진화
    • 조사 범위
  • 조사 대상 기간
  • 통화 환산율

제3장 세계의 프로스타글란딘 시장 역학

  • See Saw 분석
    • 시장 성장 촉진요인
    • 시장 과제
    • 시장 기회

제4장 세계의 프로스타글란딘 시장 업계 분석

  • Porter's Five Forces 분석
    • 구매자의 협상력
    • 공급업체의 협상력
    • 신규 참여업체의 위협
    • 대용품의 위협
    • 업계내의 경쟁
    • Porter's Five Forces 분석에 대한 미래적 접근
  • PEST 분석
    • 정치
    • 경제
    • 사회
    • 기술
  • 주요 구입 기준
  • 규제 체계
  • 투자/도입 시나리오
  • 애널리스트의 제안과 결론

제5장 종류별 : 세계의 프로스타글란딘 시장

  • 시장 현황
  • 시장 실적 - 잠재적인 모델
  • 프로스타글란딘 시장, 하위 부문 분석
    • 인간 프로스타글란딘
    • 동물용 프로스타글란딘

제6장 용도별 : 세계의 프로스타글란딘 시장

  • 시장 현황
  • 시장 실적 - 잠재적인 모델
  • 프로스타글란딘 시장, 하위 부문 분석
    • 심혈관
    • 소화기계
    • 부인과 및 산과
    • 안과
    • 기타

제7장 지역별 : 세계의 프로스타글란딘 시장

  • 프로스타글란딘 시장, 지역 시장 현황
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 기타 유럽 지역
  • 아시아
    • 중국
    • 인도
    • 일본
    • 기타 아시아태평양 지역
  • 라틴아메리카
    • 브라질
    • 멕시코
  • 기타 세계 지역
    • 남미
    • 중동 및 아프리카

제8장 경쟁 상황

  • 기업의 시장 점유율(데이터 입수 가능성별)
  • 주요 시장 전략
  • 기업 개요
    • CEPIA
    • Johnson Matthey
    • Pfizer
    • Cayman Chemical
    • EMD Millipore
    • Yonsung Fine Chemicals
    • Everlight Chemical
    • Piramal Enterprises
    • Bio-Techne Corporation
    • Mironova Labs
    • Chirogate

제9장 조사 방법

  • 조사 방법
    • 데이터마이닝
    • 분석
    • 시장 예측
    • 검증
    • 출판
    • 조사 가정
KSM 19.07.04

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF PROSTAGLANDIN MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF PROSTAGLANDIN MARKET
  • TABLE 3. PROSTAGLANDIN MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD MILLION)
  • TABLE 7. PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY TYPE 2016-2026 (USD MILLION)
  • TABLE 8. PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD MILLION)
  • TABLE 9. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 10. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 11. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 12. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 13. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 14. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 15. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 16. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 17. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 18. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 19. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 20. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 21. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 22. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 23. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 24. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 25. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 26. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 27. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 28. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 29. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 30. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 31. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 32. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 33. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 34. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 35. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 36. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 37. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 38. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 39. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 40. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 41. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 42. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 43. PROSTAGLANDIN MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 44. PROSTAGLANDIN MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 45. U.S. PROSTAGLANDIN MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 46. U.S. PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 47. U.S. PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 48. U.S. PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 49. U.S. PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 50. CANADA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 51. CANADA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 52. CANADA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 53. CANADA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 54. CANADA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 55. UK PROSTAGLANDIN MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 56. UK PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 57. UK PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 58. UK PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 59. UK PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 60. GERMANY PROSTAGLANDIN MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 61. GERMANY PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 62. GERMANY PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 63. GERMANY PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 64. GERMANY PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 65. ROE PROSTAGLANDIN MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 66. ROE PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 67. ROE PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 68. ROE PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 69. ROE PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 70. CHINA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 71. CHINA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 72. CHINA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 73. CHINA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 74. CHINA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 75. INDIA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 76. INDIA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 77. INDIA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 78. INDIA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 79. INDIA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 80. JAPAN PROSTAGLANDIN MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 81. JAPAN PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 82. JAPAN PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 83. JAPAN PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 84. JAPAN PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 85. ROAPAC PROSTAGLANDIN MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 86. ROAPAC PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 87. ROAPAC PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 88. ROAPAC PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 89. ROAPAC PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 90. BRAZIL PROSTAGLANDIN MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 91. BRAZIL PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 92. BRAZIL PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 93. BRAZIL PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 94. BRAZIL PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 95. MEXICO PROSTAGLANDIN MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 96. MEXICO PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 97. MEXICO PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 98. MEXICO PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 99. MEXICO PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 100. ROLA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 101. ROLA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 102. ROLA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 103. ROLA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 104. ROLA PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 105. ROW PROSTAGLANDIN MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
  • TABLE 106. ROW PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 107. ROW PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 108. ROW PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
  • TABLE 109. ROW PROSTAGLANDIN MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

List of Figures

  • FIG 1. PROSTAGLANDIN MARKET, RESEARCH METHODOLOGY
  • FIG 2. PROSTAGLANDIN MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. PROSTAGLANDIN MARKET, KEY TRENDS 2017
  • FIG 5. PROSTAGLANDIN MARKET, GROWTH PROSPECTS 2018-2026
  • FIG 6. PROSTAGLANDIN MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. PROSTAGLANDIN MARKET, PEST ANALYSIS
  • FIG 8. PROSTAGLANDIN MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 10. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 11. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 12. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 13. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 14. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 15. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 16. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 17. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 18. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 19. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 20. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 21. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 22. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 23. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 24. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 25. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 26. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 27. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 28. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 29. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 30. PROSTAGLANDIN MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
  • FIG 31. PROSTAGLANDIN MARKET, REGIONAL SNAPSHOT 2016 & 2026
  • FIG 32. NORTH AMERICA PROSTAGLANDIN MARKET 2016 & 2026 (USD MILLION)
  • FIG 33. EUROPE PROSTAGLANDIN MARKET 2016 & 2026 (USD MILLION)
  • FIG 34. ASIA PACIFIC PROSTAGLANDIN MARKET 2016 & 2026 (USD MILLION)
  • FIG 35. LATIN AMERICA PROSTAGLANDIN MARKET 2016 & 2026 (USD MILLION)
  • FIG 36. PROSTAGLANDIN MARKET, COMPANY MARKET SHARE ANALYSIS (2017)

Global Prostaglandin Market is valued approximately USD 461.30 million in 2018 and is anticipated to grow with a healthy growth rate of more than 4.84% over the forecast period 2019-2026. Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax. Increasing incidences of digestive problem and rising prevalence of cardiovascular diseases are the factors that contributing towards growth of global Prostaglandin market. Further, prostaglandins help in increasing concentration of cAMP, calcium ions and activate G proteins inside the cells, all of which are involved in the transfer of energy and inflammatory signaling process which is the factor that regulates their demand across various regions. However, high cost of treatment and several side-effects associated with its over-dose such as migraines and decrease the ability to fight with cancer are the factors that anticipated to restrain the market growth during the forecast period. The regional analysis of global Prostaglandin market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World.

Major market player included in this report are:

  • CEPIA
  • Johnson Matthey
  • Pfizer
  • Cayman Chemical
  • EMD Millipore
  • Yonsung Fine Chemicals
  • Everlight Chemical
  • Piramal Enterprises
  • Bio-Techne Corporation
  • Mironova Labs
  • Chirogate

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Human Prostaglandin
  • Veterinary Prostaglandin

By Application:

  • Cardiovascular
  • Digestive
  • Gynecological & Obstetrical
  • Ophthalmologic
  • Others

By Regions:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • Asia Pacific
  • China
  • India
  • Japan
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

  • Historical year - 2016, 2017
  • Base year - 2018
  • Forecast period - 2019 to 2026

Target Audience of the Global Prostaglandin Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

TABLE OF CONTENTS

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Key Trends
  • 1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Million)
    • 1.3.1. Prostaglandin Market, by Type, 2016-2026 (USD Million)
    • 1.3.2. Prostaglandin Market, by Application, 2016-2026 (USD Million)
    • 1.3.3. Prostaglandin Market, by Region, 2016-2026 (USD Million)
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Prostaglandin Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Prostaglandin Market Dynamics

  • 3.1. See Saw Analysis
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Prostaglandin Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Buyers
    • 4.1.2. Bargaining Power of Suppliers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.2. PEST Analysis
    • 4.2.1. Political Scenario
    • 4.2.2. Economic Scenario
    • 4.2.3. Social Scenario
    • 4.2.4. Technological Scenario
  • 4.3. Key Buying Criteria (On Demand)
  • 4.4. Regulatory Framework (On Demand)
  • 4.5. Investment Vs Adoption Scenario (On Demand)
  • 4.6. Analyst Recommendation & Conclusion

Chapter 5. Global Prostaglandin Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Market Performance - Potential Model
  • 5.3. Prostaglandin Market, Sub Segment Analysis
    • 5.3.1. Human Prostaglandin
      • 5.3.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 5.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 5.3.2. Veterinary Prostaglandin
      • 5.3.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 5.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)

Chapter 6. Global Prostaglandin Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Market Performance - Potential Model
  • 6.3. Prostaglandin Market, Sub Segment Analysis
    • 6.3.1. Cardiovascular
      • 6.3.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 6.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 6.3.2. Digestive
      • 6.3.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 6.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 6.3.3. Gynecological & Obstetrical
      • 6.3.3.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 6.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 6.3.4. Ophthalmologic
      • 6.3.4.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 6.3.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 6.3.5. Others
      • 6.3.5.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 6.3.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)

Chapter 7. Global Prostaglandin Market, by Regional Analysis

  • 7.1. Prostaglandin Market, Regional Market Snapshot (2016-2026)
  • 7.2. North America Prostaglandin Market Snapshot
    • 7.2.1. U.S.
      • 7.2.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 7.2.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 7.2.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 7.2.2. Canada
      • 7.2.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 7.2.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 7.2.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
  • 7.3. Europe Prostaglandin Market Snapshot
    • 7.3.1. U.K.
      • 7.3.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 7.3.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 7.3.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 7.3.2. Germany
      • 7.3.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 7.3.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 7.3.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 7.3.3. Rest of Europe
      • 7.3.3.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 7.3.3.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 7.3.3.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
  • 7.4. Asia Prostaglandin Market Snapshot
    • 7.4.1. China
      • 7.4.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 7.4.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 7.4.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 7.4.2. India
      • 7.4.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 7.4.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 7.4.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 7.4.3.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 7.4.3.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 7.4.4. Rest of Asia Pacific
      • 7.4.4.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 7.4.4.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 7.4.4.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
  • 7.5. Latin America Prostaglandin Market Snapshot
    • 7.5.1. Brazil
      • 7.5.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 7.5.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 7.5.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 7.5.2. Mexico
      • 7.5.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 7.5.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 7.5.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
  • 7.6. Rest of The World
    • 7.6.1. South America
      • 7.6.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 7.6.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 7.6.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
    • 7.6.2. Middle East and Africa
      • 7.6.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
      • 7.6.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 7.6.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)

Chapter 8. Competitive Intelligence

  • 8.1. Company Market Share (Subject to Data Availability)
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. CEPIA
      • 8.3.1.1. Overview
      • 8.3.1.2. Financial (Subject to Data Availability)
      • 8.3.1.3. Product Summary
      • 8.3.1.4. Recent Developments
    • 8.3.2. Johnson Matthey
    • 8.3.3. Pfizer
    • 8.3.4. Cayman Chemical
    • 8.3.5. EMD Millipore
    • 8.3.6. Yonsung Fine Chemicals
    • 8.3.7. Everlight Chemical
    • 8.3.8. Piramal Enterprises
    • 8.3.9. Bio-Techne Corporation
    • 8.3.10. Mironova Labs
    • 8.3.11. Chirogate

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
    • 9.1.6. Research Assumption
Back to Top
전화 문의
F A Q